74 DAFTAR PUSTAKA
1. Burrows NP, Lovell CR. Disorders of connective tissue. In : Burns T, Breathnach S, Cox N, editors. Rook’s Textbook of Dermatology. 8thedition. Wiley-Blackwell, Ltd. 2010.p.45.54-6
2. Khan SA. Keloid an update. Physician Academy [internet] 2008, 2(6): 25-9. Available from: http://www.physicians-academy.com/Upload/753676f2-e6b7-4b94-b36f-7b88236d1ef9.pdf
3. Seifert O, Mrowietz U. Keloid scarring : bench and bedside. Arch Dermatol Res 2009; 301: 259-72. DOI: 10.1007/s00403-009-0952-8
4. Robles DT, Moore E, Draznin M. Keloids: Pathophysiology and management. Dermatology Online Journal [internet] 2007; 13(3): 9-13. Available from: http://escholarship.org/uc/item/2m43548
5. Urioste SS, Arndt KA, Dover JS. Keloid and hypertrophic scars: Review and treatment strategies. Seminars in Cutaneous Medicine and Surgery [internet] 1999; 18(2): 159-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 10385284
6. Robles DT, Berg D. Abnormal wound healing: keloids. Clinics in Dermatology [internet] 2007; 25: 26-32. DOI:10.1016/j.clindermatol.2006.09.009
7. Putra IB, Jusuf NK. Studi Retrospektif Keloid di Poliklinik Kulit dan Kelamin RSUP H. Adam Malik Medan. 12th Asia-Pasific Environmental and Occupational Dermatology Symposium; 2013 Oct 23-26; Yogyakarta: Indonesia
8. Juckett G, Adams HH. Management of keloids and hypertrophic scars. Am Fam Physician 2009; 80(3): 253-260. Available from: http://www.aafp.org/afp/20090801/253-s1.html.
9. Kranendonk S, Obagi S. An algorithmic approach to hypertrophic scars and keloids: Maximizing nonsurgical options. Cosmetic Dermatology [internet] 2011; 24(1). Available from: http://www.cosderm.com/fileadmin/qhi_archive/ ArticlePDF/CD/024010028.pdf
10. Wolfram D, Tzankov A, Pulzi P. Hypertrophic scars and keloids – A review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 2009; 35: 171-81. DOI: 10.1111/j.1524-4725.2008.34406.x
75
12. Darougheh A, Asilian A, Shariati F. Intralesional triamcinolone alone or in combination with 5-flurouracil for the treatment of keloid and hypertrophic scars. Clinical and Experimental Dermatology 2007; 34: 219-23. DOI:10.1111/j.1365-2230.2007.02631.x
13. Hatamipur E, Mehrabi S, Hatamipoor M. Effects of combined intralesional 5-flurouracil and topical silicone in prevention of keloid: A double blind randomized clinical trial study. Acta Medica Iranica [internet] 2011; 49(3): 127-30. Available from: http://acta.tums.ac.ir/files/journals/1/articles/4307/public/ 4307-4664-1-PB.pdf
14. Perdanakusuma D. Parut abnormal. Dalam : Perdanakusuma D, Noer MS, editor. Penanganan parut hipertropik dan keloid. Airlangga University Press. 2006 : 13-26
15. Gautglitz GG, Korting HC, Pavicic T, et al. Hypertropic scarring and keloids : Pathomechanisms and current and emerging treatment strategies. Mol Med 2011; 17(1) : 113 – 25. DOI: 10.2119/molmed.2009.00153
16. Butler PD, Longaker MT, Yang GP. Current progress in Keloid Research and Treatment. J. Am Coll of Surg 2008; 206(4), 731 – 40. DOI:10.1016/j.jamcollsurg.2007.12.001
17. Alaish SM, Yager DR. Hyaluronic acid metabolism in keloid fibroblast. Journal of Pediatric Surgery [internet] 1995; 30(7): 949-52. Available from: http://www.jpedsurg.org/article/0022-3468%2895%2990319-4/pdf
18. Lee SS, Yosipovitch G, Chan YH, et al. Pruritus, pain, and small nerve fiber function in keloids: a controlled study. J Am Acad Dermatol. 2004;51:1002-6. DOI:10.1016/j.jaad.2004.07.054
19. Miteva M, Romanelli P. Hypertrophic and keloidal scars. In: Tosti A, Padova MP, Beer KR, editors. Acne scars classification and treatment. Informa Healthcare: 11-7
20. Hochman B, Localli RF. Intralesional triamcinolone acetonide for keloid treatment: A systemic review . Aesth plast Surg 2008; 32: 705-9. DOI 10.1007/s00266-008-9152-8
21. Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg [internet] 2012; 125: 557-567. DOI: 10.1097/PRS.0b013e3181c82dd5
22. Cho SB, Lee JH, Lee SH. Efficacy and safety of 1064 nm Qswitch Nd:YAG laser with low fluence for keloids and hypertrophic scars. Journal European Academy of Dermatology and Venerreology. 2010;24 : 1070-4. DOI: 10.1111/j.1468-3083.2010.03593.x
76
24. Gauglitz GG. Management of keloids and hypertrophic scars: current and emerging options. Clinical, Cosmetic and Investigational Dermatology [internet] 2013; 6 : 103–14. Available from: http://dx.doi.org/10.2147/CCID.S35252
25. Berman B, Villa AM, Ramirez CC. Novel opportunities in the treatment and prevention of scarring. J Cutan Med Sur [internet] 2005: 32-6. Available from: http://link.springer.com/content/pdf/10.1007/s10227-004-0806-0.pdf
26. Qiao WX, Kai LY, Chun Q, et al. A Review of the Effectiveness of Antimitotic Drug Injections for Hypertrophic Scars and Keloids. Ann Plast Surg 2009; 63: 688–92. DOI: 10.1097/SAP.0b013e3181978753
27. Putra IB. Pengaruh ekstrak kelopak bunga rosella (Hibiscus sabdariffa l) terhadap penghambatan proliferasi sel fibroblast keloid manusia. Disertasi. Medan : Program Doktor S3 Ilmu Kedokteran Fakultas Kedokteran Universitas Sumatra Utara; 2012
28. Kelly AP. Update on the management of keloids. Semin Cutan Med Surg 2009; 28 : 71-6. DOI:10.1016/j.sder.2009.04.002
29. Nanda S, Reddy BS. Intralesional 5-Fluorouracil as a treatment modality of keloids. Dermatol Surg [internet] 2004; 30(1): 54-6. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4725.2004.29382.x/pdf
30. Qiao WX, Kai LY, Yong WZ. Antimitotic drug injections and radiotherapy : A review of the effectiveness of the treatment for hypertrophic scars and keloid. International Journal of Lower Extremity Wound 2008; 7(3): 151-9. DOI: 10.1177/1534734608322099
31. Haurani MJ, Foreman K, Yang JJ. 5-flourouracil treatment of problematic scars. Plastic Reconstr Surg 2009; 123: 139-47. DOI: 10.1097/PRS.0b013e3181904d1b 32. Sadeghinia A, Sadeghinia S. Comparison of the efficacy of intralesional
triamcinolon and 5-flurouracil tattooing for the treatment of keloids. Dermatol Surg 2012; 38: 104-9. DOI: 10.1111/j.1524-4725.2011.02137.x
33. Sharma S, Bassi R, Gupta A. Treatment of small keloids with intralesional 5-fluorouracil alone vs intralesional triamcinolone with 5-5-fluorouracil. Journal of Pakistan Association of Dermatologist [internet] 2012; 22: 35-40. Available from: http://www.jpad.org.pk/January-March2012/7.Original_article_Treatment_ keloids_5-FU_vs_5-FU_plus_triamcinolone_proofread.pdf
34. Gupta S, Kalra A. Efficacy and safety of intralesional 5-Fluorouracil in the treatment of keloids. Dermatology [internet] 2002; 204(2): 130-32. Available from: http://karger.com/journals/drm
77
36. Kontochristopoulus G, Stefanaki C, Panagiotopoulos A, et all. Intralesional 5-Fluorouracil in the treatment of keloids: an open clinical trial and histopathologic study. J Am Acad Dermatol. 2005; 52(3): 474-9. DOI:10.1016/j.jaad.2004.09.018 37. Pratchyapruit W, Vashrangsi N. A new therapeutic modality intralesional
5-flourouracil in the treatment of keloids and hypertrophic scar. Institute of Dermatology 2010; (10)2: 157-63. DOI 10.1007/s00266-006-0253-y
38. Werth VP. Systemic glucocorticoids. In: Wolff K, Goldsmith LA, Katz SI, Gilrechrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s dermatology in general medicine. 7thedition. New York: Mc Graw-Hill.2008.p.2147-52
39. Bayat A, Arscott G, Ollier WER, Grouther DA, Ferguson MWJ. Keloid disease: clinical relevance of single versus multiple site scars. The British Association of Plastic Surgeons 2005; 58: 28-37. DOI:10.1016/j.bjps.2004.04.024
40. Naeni FF, Najafian J, Ahmadpour K. Bleomycin tattooing as a promising therapeutic modality in large keloids and hypertrophic scars. Dermatol Surg [internet] 2006; 32: 1023-30. Available from: http://onlinelibrary.wiley.com/ doi/10.1111/j.1524-4725.2006.32225.x/pdf.
41. Perdanasari AT, Lazzeri D, Su W, Xi W, Zheng Z, Ke Li, et al. Recent developments in the use of intralesional injections keloid treatment. Arch Plast Surg [internet] 2014; 41: 620-9. Available from: http://dx.doi.org/10.5999/aps.2014.41.6.620
42. Kelly AP. Medical and surgical therapies for keloids. Dermatologic Therapy. 2004,17: 212–8. DOI:10.1016/J.Sder.2009.04.002
